Your browser doesn't support javascript.
loading
Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial.
Le Gouill, Steven; Morschhauser, Franck; Chiron, David; Bouabdallah, Krimo; Cartron, Guillaume; Casasnovas, Olivier; Bodet-Milin, Caroline; Ragot, Sylviane; Bossard, Céline; Nadal, Nathalie; Herbaux, Charles; Tessoulin, Benoit; Tchernonog, Emmanuelle; Rossi, Cédric; McCulloch, Rory; Gastinne, Thomas; Callanan, Mary B; Rule, Simon.
Afiliação
  • Le Gouill S; Service d'hématologie clinique du Centre Hospitalier Universitaire (CHU) de Nantes, INSERM Centre de Recherche en Cancérologie et Immunologie Nantes Angers (CRCINA) Nantes-Angers, Nantes Excellence Trajectory (NeXT) Université de Nantes, Nantes, France.
  • Morschhauser F; CHU Lille, Université de Lille, Lille, France.
  • Chiron D; INSERM, CNRS, Université de Nantes, Nantes, France.
  • Bouabdallah K; CHU Bordeaux, Bordeaux, France.
  • Cartron G; CHU Montpellier, Institut de Génétique Moléculaire de Montpellier, INSERM, Université de Montpellier, Montpellier, France.
  • Casasnovas O; CHU Dijon, INSERM, Dijon, France.
  • Bodet-Milin C; Service de médecine nucléaire CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Université de Nantes, Nantes, France.
  • Ragot S; Université de Bourgogne Faculté de Médecine, INSERM, CHU Dijon, Dijon, France.
  • Bossard C; Service d'anatomopathologie, CHU de Nantes, Nantes, France.
  • Nadal N; CHU Dijon, INSERM, Dijon, France.
  • Herbaux C; CHU Lille, Lille, France.
  • Tessoulin B; Service d'hématologie clinique du Centre Hospitalier Universitaire (CHU) de Nantes, INSERM Centre de Recherche en Cancérologie et Immunologie Nantes Angers (CRCINA) Nantes-Angers, Nantes Excellence Trajectory (NeXT) Université de Nantes, Nantes, France.
  • Tchernonog E; CHU Montpellier, Montpellier, France.
  • Rossi C; CHU Dijon, INSERM, Dijon, France.
  • McCulloch R; Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom; and.
  • Gastinne T; Service d'hématologie clinique du CHU de Nantes, Nantes, France.
  • Callanan MB; Université de Bourgogne Faculté de Médecine, INSERM, CHU Dijon, Dijon, France.
  • Rule S; Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom; and.
Blood ; 137(7): 877-887, 2021 02 18.
Article em En | MEDLINE | ID: mdl-33181832
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Célula do Manto Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Célula do Manto Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 Idioma: En Ano de publicação: 2021 Tipo de documento: Article